Your browser doesn't support javascript.
loading
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.
Weischenfeldt, Joachim; Dubash, Taronish; Drainas, Alexandros P; Mardin, Balca R; Chen, Yuanyuan; Stütz, Adrian M; Waszak, Sebastian M; Bosco, Graziella; Halvorsen, Ann Rita; Raeder, Benjamin; Efthymiopoulos, Theocharis; Erkek, Serap; Siegl, Christine; Brenner, Hermann; Brustugun, Odd Terje; Dieter, Sebastian M; Northcott, Paul A; Petersen, Iver; Pfister, Stefan M; Schneider, Martin; Solberg, Steinar K; Thunissen, Erik; Weichert, Wilko; Zichner, Thomas; Thomas, Roman; Peifer, Martin; Helland, Aslaug; Ball, Claudia R; Jechlinger, Martin; Sotillo, Rocio; Glimm, Hanno; Korbel, Jan O.
Afiliação
  • Weischenfeldt J; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.
  • Dubash T; The Finsen Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Drainas AP; Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark.
  • Mardin BR; Department of Translational Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Chen Y; Division of Translational Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Stütz AM; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.
  • Waszak SM; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.
  • Bosco G; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Halvorsen AR; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.
  • Raeder B; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.
  • Efthymiopoulos T; Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Cologne, Germany.
  • Erkek S; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
  • Siegl C; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.
  • Brenner H; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.
  • Brustugun OT; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.
  • Dieter SM; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Northcott PA; Department of Translational Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Petersen I; Division of Translational Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Pfister SM; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schneider M; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
  • Solberg SK; Department of Oncology, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
  • Thunissen E; Department of Translational Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Weichert W; Division of Translational Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Zichner T; Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Thomas R; Institute of Pathology, Jena University Hospital, Jena, Germany.
  • Peifer M; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Helland A; General Surgery, Heidelberg University Clinics, Heidelberg, Germany.
  • Ball CR; Department of Cardiothoracic Surgery, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
  • Jechlinger M; Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
  • Sotillo R; Institute of Pathology, Technical University Munich, Munich, Germany.
  • Glimm H; Department of Pathology, University Hospital Cologne, Cologne, Germany.
  • Korbel JO; German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Nat Genet ; 49(1): 65-74, 2017 01.
Article em En | MEDLINE | ID: mdl-27869826
Extensive prior research focused on somatic copy-number alterations (SCNAs) affecting cancer genes, yet the extent to which recurrent SCNAs exert their influence through rearrangement of cis-regulatory elements (CREs) remains unclear. Here we present a framework for inferring cancer-related gene overexpression resulting from CRE reorganization (e.g., enhancer hijacking) by integrating SCNAs, gene expression data and information on topologically associating domains (TADs). Analysis of 7,416 cancer genomes uncovered several pan-cancer candidate genes, including IRS4, SMARCA1 and TERT. We demonstrate that IRS4 overexpression in lung cancer is associated with recurrent deletions in cis, and we present evidence supporting a tumor-promoting role. We additionally pursued cancer-type-specific analyses and uncovered IGF2 as a target for enhancer hijacking in colorectal cancer. Recurrent tandem duplications intersecting with a TAD boundary mediate de novo formation of a 3D contact domain comprising IGF2 and a lineage-specific super-enhancer, resulting in high-level gene activation. Our framework enables systematic inference of CRE rearrangements mediating dysregulation in cancer.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Insulin-Like II / Regulação Neoplásica da Expressão Gênica / Elementos Facilitadores Genéticos / Proteínas Substratos do Receptor de Insulina / Variações do Número de Cópias de DNA / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Insulin-Like II / Regulação Neoplásica da Expressão Gênica / Elementos Facilitadores Genéticos / Proteínas Substratos do Receptor de Insulina / Variações do Número de Cópias de DNA / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha